Syringes have to withstand high pressures
during angioplasty. Polypropylene (PP) syringes
used so far, have limitations in withstanding
these pressures, particularly at a higher
level. A new type of syringe from Eastar PET
has successfully withstood 50% higher pressure
compared to PP. Designed to operate in conjunction
with a new type of injector that controls
the delivery of a contrast medium into the
patient's blood system, SEDAT's (injection
moulder) ELS 200 ml-angiographic syringe is
innovation both in concept and performance.
In comparison with the previous state-of-the-art
syringe moulded in polypropylene, it can be
fit to the injector by simply sliding it into
a holding sleeve and locking it in position
instead of the 3-4 fitting steps previously
required. Additionally PET offers excellent
clarity, excellent stress crack resistance.
This new type of syringe has been marketed
worldwide since early 2005. Due to the improved
performance it provides, combined with user-friendliness
and ease of operation, the product has opened
a new market niche by filling a gap in the
delivery device offer to the medical sector.
